Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.07M Sell
11,168
-2,245
-17% -$198K 0.03% 149
2025
Q4
$1.26M Sell
13,413
-577
-4% -$62.2K 0.04% 144
2025
Q3
$1.68M Sell
13,990
-460
-3% -$56.1K 0.05% 112
2025
Q2
$1.94M Buy
14,450
+40
+0.3% +$4.52K 0.06% 103
2025
Q1
$1.34M Sell
14,410
-1,320
-8% -$126K 0.05% 122
2024
Q4
$1.4M Buy
15,730
+1,740
+12% +$143K 0.05% 120
2024
Q3
$992K Sell
13,990
-700
-5% -$46.8K 0.04% 145
2024
Q2
$991K Sell
14,690
-1,340
-8% -$83.7K 0.04% 140
2024
Q1
$974K Buy
16,030
+3,330
+26% +$188K 0.04% 150
2023
Q4
$618K Sell
12,700
-1,930
-13% -$84.3K 0.03% 171
2023
Q3
$552K Buy
14,630
+6,250
+75% +$265K 0.03% 168
2023
Q2
$369K Buy
8,380
+930
+12% +$34.3K 0.02% 203
2023
Q1
$257K Buy
+7,450
New +$247K 0.01% 235

Other funds holding NFLX

Aspiriant LLC's NFLX Position: Q1 2026 in Review

Aspiriant LLC reduced its Netflix (NFLX) stake by 17% in Q1 2026, selling an estimated $198K and leaving 11,168 shares worth $1.07M. The position accounts for 0.03% of the portfolio, ranked #149.

Aspiriant LLC first reported a position in NFLX in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.94M in Q2 2025. 3,606 funds tracked by Wall St. Rank hold NFLX as of Q1 2026.

  • Aspiriant LLC held 11,168 shares of Netflix worth $1.07M as of Q1 2026.
  • Aspiriant LLC sold 2,245 Netflix shares in Q1 2026, an estimated $198K.
  • Netflix made up 0.03% of Aspiriant LLC's portfolio in Q1 2026, its #149 holding.
  • Aspiriant LLC first reported a position in Netflix in Q1 2023 and has held it in 13 quarters since.
  • Aspiriant LLC's Netflix position peaked at $1.94M in Q2 2025.
  • 3,606 funds tracked by Wall St. Rank held Netflix as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.